Explore the latest in cardiovascular disease risk factors, including diabetes, dyslipidemia, hypertension, tobacco and smoking, and more.
This JAMA Patient Page reviews the 2020 US Preventive Services Task Force’s recommendation to offer behavioral counseling to promote healthy diet and physical activity to prevent cardiovascular disease in adults with CVD risk factors (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on behavioral counseling to promote healthy diet and physical activity for cardiovascular disease (CVD) prevention summarizes published evidence on the benefits and harms of behavioral counseling to promote healthy diet and physical activity for CVD prevention in adults with cardiovascular risk factors.
This 2020 US Preventive Services Task Force Recommendation Statement recommends offering or referring adults with CVD risk factors to behavioral counseling interventions to promote a healthy diet and physical activity (B recommendation).
This cohort study assesses 10-year use, adherence, cost, and outcome trends in statin therapy for atherosclerotic cardiovascular disease in US adults using nationwide research center database information.
This cohort study characterizes the relative association of conventional and novel biomarkers in Mediterranean diet–related type 2 diabetes risk reduction in a US population.
This cross-sectional study examines the intraindividaul discrepancies in blood pressure estimates and classifications based on different BP estimation protocols.
This serial cross-sectional study assesses whether any race/ethnicity-specific changes occurred from before to after publication of the Eighth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure panel member report for the initiation of antihypertensive medication classes in a 5% sample of Medicare beneficiaries aged 66 years or older.
This randomized clinical trial assesses the efficacy of α-cyclodextrin for cholesterol control and that of hydrolyzed ginseng for glycemic control in people with prediabetes and overweight or obesity.
This meta-analysis assesses randomized clinical trials of statins to determine the time to benefit for prevention of a first major adverse cardiovascular event in adults aged 50 to 75 years.
This randomized trial examines the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA and DHA (omega-3 CA) with documented favorable effects on lipid and inflammatory markers in patients with atherogenic dyslipidemia and high cardiovascular risk.
This secondary exploratory analysis evaluates the association between baseline low-density lipoprotein cholesterol and the percentage low-density lipoprotein cholesterol reduction with a statin, ezetemibe, and a PCSK9 inhibitor using data from 3 randomized clinical trials
This post hoc analysis of data from the Systolic Blood Pressure Intervention Trial determines the association between the proportion of West African ancestry with response to antihypertensive medication, blood pressure control, kidney function, and risk of adverse cardiovascular events among self-identified Black individuals.
This cross-sectional study evaluates which health indicators have improved or worsened among Black and Hispanic middle-aged and older adults since the Minority Health and Health Disparities Research and Education Act of 2000.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: